Overview
The June 2026 quarter marked a weaker operating period, with revenue down 18.2% year-on-year and net profit down 53.6%. Arpico Insurance is a Sri Lankan life and health insurer serving individual and corporate customers through an extended distribution network, with group insurance and a Life Insurance Fund also central to its operations.
Price performance
The share closed at LKR 27.70 on 14 August 2026. It fell 15.6% over three months and 29.4% over six months, versus ASPI declines of 5.6% and 9.2%; over one year, the share gained 4.0% while the index gained 9.3%.
The price sits at 7.3% of its 52-week range, only 4.4% above the 52-week low and 35.0% below the high. Recent volatility at 51.7% annualised is 20.1% below its own one-year level, while 20-day volume is 56.2% below its 60-day average. The three-month fall has no company news explanation in the last 30 days.
Valuation
The valuation is stretched against earnings: the P/E of 231 is at the 89th percentile among insurance peers, compared with a sector median of 11.82. By contrast, the P/B of 1.07 is at the 30th percentile versus a sector median of 1.73, consistent with the company's very low audited return on equity of 0.5% for 2025.
No dividend yield, dividend-per-share figure or dividend history is provided, so the payout cannot be assessed for direction or sustainability.
News and sentiment
Coverage was normal over the 90-day period, with four material articles: one positive, two negative and one neutral. The positive items concerned a board appointment and an audit committee appointment, while the negative disclosures related to 2025 profit information and an accompanying filing.
No confirmed or announced corporate actions are recorded. The news flow is not unusually loud, but its balance is slightly negative.
Financials
The June 2026 group quarter produced revenue of LKR 427 million, down 18.2% from LKR 522 million in the comparable group quarter, and net profit of LKR 17 million, down LKR 20 million or 53.6%. Net margin narrowed from 7.2% to 4.0%, and the latest result was the worst of the three comparable June quarters in the company's history. Gross and operating margins were not reported for either period.
The latest quarter's equity was LKR 1.71 billion, compared with LKR 1.92 billion in June 2025. The share count was broadly unchanged at 66.23 million, so the earnings deterioration is not explained by a recent change in shares outstanding. Operating profit and the below-the-line drag were not reported for the latest quarter, preventing a split between operating weakness and finance costs, tax, associates or foreign exchange effects.
The audited year ended December 2025 was substantially weaker than the latest quarterly profit suggests, with net profit of LKR 8 million and net margin of 0.3%. December is structurally the strongest quarter for net margin, while September is the weakest, but June is not the seasonal extreme and the latest result remains weak against its comparable June history.
Risks
The main financial risk is the combination of falling earnings and balance-sheet leverage. Group debt was LKR 426 million at December 2025, equal to 25.2% of owners' equity, up from 21.0% on the prior company-basis comparison. Interest cover is not reported.
Current ratio and cash conversion are not applicable measures for an insurer in this dataset, so liquidity cannot be judged through those conventional company ratios. The broader environment adds pressure to investment returns: Treasury bill yields have eased to 9.44% for three months and 10.01% for twelve months, which can reduce reinvestment income for fixed-income portfolios, while inflation reached 7.3%.
Outlook
The next identifiable company event is the filing for the quarter ending 30 September 2026. As at 16 August 2026, it is expected between 7 November 2026 and 7 January 2027 and will supersede the June figures used here; the key information will be whether the earnings weakness is confined to the current period or persists.
Insurance-sector news is quiet, while lower Treasury yields and elevated inflation shape the operating backdrop. The available data cannot establish how those market conditions are affecting Arpico Insurance's investment income or claims performance, so the next filing is the clearest evidence point.